Roche Holding AG (RHHVF)
244.10
+2.74
(+1.13%)
USD |
OTCM |
May 09, 16:00
Roche EPS Diluted (TTM): 16.01 for Dec. 31, 2023
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 16.01 |
June 30, 2023 | 14.89 |
December 31, 2022 | 15.94 |
June 30, 2022 | 18.68 |
December 31, 2021 | 17.69 |
June 30, 2021 | 17.90 |
December 31, 2020 | 17.64 |
June 30, 2020 | 15.36 |
December 31, 2019 | 15.65 |
June 30, 2019 | 13.68 |
December 31, 2018 | 12.35 |
June 30, 2018 | 12.36 |
December 31, 2017 | 10.18 |
June 30, 2017 | 11.35 |
December 31, 2016 | 11.31 |
June 30, 2016 | 10.76 |
December 31, 2015 | 10.68 |
June 30, 2015 | 10.91 |
Date | Value |
---|---|
December 31, 2014 | 11.77 |
June 30, 2014 | 13.91 |
December 31, 2013 | 14.00 |
June 30, 2013 | 13.85 |
December 31, 2012 | 11.82 |
June 30, 2012 | 10.68 |
December 31, 2011 | 12.36 |
June 30, 2011 | 10.79 |
December 31, 2010 | 9.588 |
June 30, 2010 | 10.66 |
December 31, 2009 | 8.516 |
June 30, 2009 | 7.693 |
December 31, 2008 | 9.426 |
June 30, 2008 | 10.17 |
December 31, 2007 | 9.433 |
June 30, 2007 | 8.218 |
December 31, 2006 | 7.307 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (TTM) Range, Past 5 Years
13.68
Minimum
Jun 2019
18.68
Maximum
Jun 2022
16.34
Average
15.97
Median
EPS Diluted (TTM) Benchmarks
AC Immune SA | -0.7095 |
CRISPR Therapeutics AG | -1.93 |
Addex Therapeutics Ltd | -18.66 |
NLS Pharmaceutics Ltd | -0.50 |
Molecular Partners AG | -2.104 |